• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有效传达全面的肿瘤基因组分析结果:减轻晚期癌症患者的不确定性。

Effectively communicating comprehensive tumor genomic profiling results: Mitigating uncertainty for advanced cancer patients.

作者信息

Bartley Nicci, Best Megan C, Biesecker Barbara B, Fisher Alana, Goldstein David, Meiser Bettina, Thomas David M, Ballinger Mandy L, Butow Phyllis

机构信息

School of Psychology, The University of Sydney, Sydney, Australia.

School of Psychology, The University of Sydney, Sydney, Australia; Institute of Ethics and Society, The University of Notre Dame, Sydney, Australia.

出版信息

Patient Educ Couns. 2022 Feb;105(2):452-459. doi: 10.1016/j.pec.2021.05.018. Epub 2021 May 14.

DOI:10.1016/j.pec.2021.05.018
PMID:34016496
Abstract

OBJECTIVE

To understand advanced cancer patients' experience of uncertainty when receiving comprehensive tumor genomic profiling (CTGP) results, and their perceptions of how healthcare provider (HCP) communication impacts uncertainty.

METHODS

Thirty-seven semi-structured interviews with advanced cancer patients were conducted within two weeks of patients receiving CTGP results. Transcripts were thematically analyzed, using an inductive approach.

RESULTS

We identified three themes that illustrate patient experience of uncertainties when receiving CTGP results: 1. Type and degree of uncertainty fluctuates along with changing illness circumstances and the nature of the CTGP results; 2. HCPs' co-ordination of care and communication shapes uncertainty, with immediate, clearer and simpler information promoting certainty; and 3. Patients felt that communicating results to reduce relatives' uncertainty is important, with patients choosing the time and process for achieving this and desiring HCPs support.

CONCLUSION

Oncology patients are confronted with an array of uncertainties. Clear, simple communication from HCPs about results and their implications, and support to manage uncertainty, will be of benefit.

PRACTICE IMPLICATIONS

If CTGP is to become routine clinical practice, clear communication will be crucial in reducing uncertainty. Awareness of potential uncertainties experienced by patients when receiving results, will assist HCPs to address uncertainties, reduce uncertainty where possible, and offer targeted support to patients struggling with uncertainty.

摘要

目的

了解晚期癌症患者在收到综合肿瘤基因组分析(CTGP)结果时对不确定性的体验,以及他们对医疗服务提供者(HCP)沟通如何影响不确定性的看法。

方法

在患者收到CTGP结果后的两周内,对37名晚期癌症患者进行了半结构化访谈。采用归纳法对访谈记录进行了主题分析。

结果

我们确定了三个主题,阐述了患者在收到CTGP结果时对不确定性的体验:1. 不确定性的类型和程度随着病情变化以及CTGP结果的性质而波动;2. HCP的护理协调和沟通塑造了不确定性,即时、更清晰和更简单的信息可增强确定性;3. 患者认为向亲属传达结果以减少他们的不确定性很重要,患者会选择传达的时间和方式,并希望得到HCP的支持。

结论

肿瘤患者面临一系列不确定性。HCP就结果及其影响进行清晰、简单的沟通,并提供管理不确定性的支持,将有所助益。

实践意义

如果CTGP要成为常规临床实践,清晰的沟通对于减少不确定性至关重要。了解患者在收到结果时可能经历的潜在不确定性,将有助于HCP解决不确定性,尽可能降低不确定性,并为在不确定性中挣扎的患者提供有针对性的支持。

相似文献

1
Effectively communicating comprehensive tumor genomic profiling results: Mitigating uncertainty for advanced cancer patients.有效传达全面的肿瘤基因组分析结果:减轻晚期癌症患者的不确定性。
Patient Educ Couns. 2022 Feb;105(2):452-459. doi: 10.1016/j.pec.2021.05.018. Epub 2021 May 14.
2
Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patients.晚期癌症患者全面肿瘤基因组分析结果的心理影响
Patient Educ Couns. 2022 Jul;105(7):2206-2216. doi: 10.1016/j.pec.2022.01.011. Epub 2022 Jan 24.
3
Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study.将全面肿瘤基因组分析结果返回给晚期癌症患者:一项定性研究。
Support Care Cancer. 2022 Oct;30(10):8201-8210. doi: 10.1007/s00520-022-07272-3. Epub 2022 Jul 9.
4
Patient and Healthcare Provider Perspectives on the Implementation of a Web-Based Clinical Communication System for Cancer: A Qualitative Study.患者和医疗保健提供者对基于网络的癌症临床沟通系统实施的看法:一项定性研究。
Curr Oncol. 2022 Nov 3;29(11):8401-8414. doi: 10.3390/curroncol29110662.
5
Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling.接受全面肿瘤基因组分析的罕见晚期癌症患者对癌症进展恐惧的纵向模式。
Psychooncology. 2021 Nov;30(11):1920-1929. doi: 10.1002/pon.5764. Epub 2021 Jul 14.
6
Pursuing germline genome sequencing to reduce illness uncertainty may involve additional uncertainties for cancer patients: A mixed-methods study.开展种系基因组测序以减少疾病不确定性可能会给癌症患者带来更多的不确定性:一项混合方法研究。
J Genet Couns. 2021 Aug;30(4):1143-1155. doi: 10.1002/jgc4.1398. Epub 2021 Mar 31.
7
Preoperative concerns of patients undergoing general surgery.普外科手术患者的术前关注点。
Patient Educ Couns. 2021 Jun;104(6):1467-1473. doi: 10.1016/j.pec.2020.11.010. Epub 2020 Nov 21.
8
Understanding communication between patients and healthcare professionals regarding comprehensive biomarker testing in precision oncology: A scoping review.理解患者与医疗保健专业人员在精准肿瘤学中综合生物标志物检测方面的沟通:范围综述。
Cancer Med. 2024 Feb;13(3):e6913. doi: 10.1002/cam4.6913. Epub 2024 Jan 31.
9
eHealth, Participatory Medicine, and Ethical Care: A Focus Group Study of Patients' and Health Care Providers' Use of Health-Related Internet Information.电子健康、参与式医疗与伦理关怀:一项关于患者及医疗服务提供者对健康相关互联网信息使用情况的焦点小组研究
J Med Internet Res. 2015 Jun 22;17(6):e155. doi: 10.2196/jmir.3792.
10
Patient and healthcare provider knowledge, attitudes and barriers to handover and healthcare communication during chronic disease inpatient care in India: a qualitative exploratory study.印度慢性病住院护理期间患者及医疗服务提供者关于交接班和医疗沟通的知识、态度及障碍:一项定性探索性研究
BMJ Open. 2019 Nov 11;9(11):e028199. doi: 10.1136/bmjopen-2018-028199.

引用本文的文献

1
Patient and physician preferences for cancer panel testing in Japan: a best-worst scaling study.日本患者和医生对癌症综合检测的偏好:一项最佳-最差标度研究。
BMJ Open. 2025 Aug 26;15(8):e097620. doi: 10.1136/bmjopen-2024-097620.
2
What Do Patients With Cancer Know, or Want to Know, About Genomic Tumor Sequencing and Genetic Testing? A State-of-the-Art Review.癌症患者对基因组肿瘤测序和基因检测了解多少,或者想了解什么?一项最新综述。
J Adv Pract Oncol. 2024 Sep 11:1-14. doi: 10.6004/jadpro.2024.15.8.14.
3
Understanding communication between patients and healthcare professionals regarding comprehensive biomarker testing in precision oncology: A scoping review.
理解患者与医疗保健专业人员在精准肿瘤学中综合生物标志物检测方面的沟通:范围综述。
Cancer Med. 2024 Feb;13(3):e6913. doi: 10.1002/cam4.6913. Epub 2024 Jan 31.
4
Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study.将全面肿瘤基因组分析结果返回给晚期癌症患者:一项定性研究。
Support Care Cancer. 2022 Oct;30(10):8201-8210. doi: 10.1007/s00520-022-07272-3. Epub 2022 Jul 9.
5
Co-designing models for the communication of genomic results for rare diseases: a comparative study in the Czech Republic and the United Kingdom.共同设计罕见病基因检测结果沟通模型:捷克共和国与英国的比较研究
J Community Genet. 2022 Jun;13(3):313-327. doi: 10.1007/s12687-022-00589-w. Epub 2022 May 6.